Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,264,363 papers from all fields of science
Search
Sign In
Create Free Account
Malignant neoplasm of central nervous system
Known as:
Cancer of the Central Nervous System
, Malignant Tumor of CNS
, Malignant CNS Neoplasms
Expand
A primary or metastatic malignant neoplasm involving the brain or spinal cord. Representative examples include anaplastic astrocytoma, glioblastoma…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Broader (2)
CNS disorder
Central Nervous System Neoplasms
Central Nervous System
Neoplastic Cell
Nervous system structure
Turcot Syndrome Type 1
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Hybrid Gd3+/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines.
Hélène Lajous
,
R. Riva
,
+7 authors
E. Garçion
Biomaterials Science
2018
Corpus ID: 51700660
Glioblastoma is the most frequent and aggressive primary malignant tumor of the central nervous system with a gloomy prognosis…
Expand
Review
2008
Review
2008
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.
A. Heimberger
,
W. Priebe
Recent Patents on CNS Drug Discovery
2008
Corpus ID: 21901271
High-grade primary and metastatic central nervous system (CNS) tumors are common, deadly, and refractory to conventional therapy…
Expand
2004
2004
Use of donors with central nervous system malignancies: Proceed with caution
J. Buell
2004
Corpus ID: 71603589
2001
2001
Reconciling animal and human data in a cancer risk assessment of acrylonitrile.
M. Schulz
,
Irva Hertz-Picciotto
,
L. Todd
,
L. Ball
Scandinavian Journal of Work, Environment and…
2001
Corpus ID: 12662981
OBJECTIVES Bioassays of rats exposed to acrylonitrile have consistently detected an elevated incidence of central nervous system…
Expand
1998
1998
A new pineoblastoma cell line, PER-480, with der(10)t(10;17), der(16)t(1;16), and enhanced MYC expression in the absence of gene amplification.
U. Kees
,
D. Spagnolo
,
+5 authors
J. Biegel
Cancer Genetics and Cytogenetics
1998
Corpus ID: 8972271
1998
1998
Synthesis and anticancer evaluation of certain γ-aryloxymethyl-α-methylene-γ-phenyl-γ-butyrolactones
Tai‐Chi Wang
,
Kuan-Han Lee
,
Yeh‐long Chen
,
S. Liou
,
C. Tzeng
1998
Corpus ID: 46437337
1996
1996
The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation
J. Lamond
,
M. Mehta
,
D. Boothman
Journal of Neuro-Oncology
1996
Corpus ID: 32136422
SummaryDespite innovations in imaging, surgery, and radiation therapy, local failure remains the principle clinical problem in…
Expand
1994
1994
Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.
J. Jurayj
,
R. Haugwitz
,
R. Varma
,
K. Paull
,
J. Barrett
,
M. Cushman
Journal of Medicinal Chemistry
1994
Corpus ID: 25195435
9-Methoxy-2-methylellipticinium acetate (6), along with the 9-methyl and 9-chloro derivatives (7, and 8, respectively) have shown…
Expand
1993
1993
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin.
M. Lee
,
A. L. Rhodes
,
M. D. Wyatt
,
M. D’Incalci
,
S. Forrow
,
J. Hartley
Journal of Medicinal Chemistry
1993
Corpus ID: 24854181
Imidazole containing analogues 7, 10, and 17 of distamycin wherein the C-terminus contain a dimethylamino moiety have been shown…
Expand
1990
1990
Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors
L. Feun
,
N. Savaraj
,
H. Landy
,
H. Levin
,
T. Lampidis
Journal of Neuro-Oncology
1990
Corpus ID: 24851764
A phase 11 trial of Homoharringtonine (HHT) was performed in 15 patients with recurrent or progressive malignant glioma. The drug…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required